Researchers cite more than four decades worth of research into GHK-Cu, including non-human and human studies that show that the peptide is safe and non-toxic [1]
It also supports the release and synthesis of acetylcholine, as well as enhances the release of dopamine from neurons and helps it bind to dopamine receptors
Research suggests that GLP-1/GIP medications work best when used consistently over an extended period
282 Clinical exploration of Inotersen in ATTR-CM is still in progress, with a phase 2 trial (NCT03702829) underway
This finding triggered the boxed warning because the FDA applies precautionary standards, if an animal study shows a serious risk, the warning goes on the label until human data proves otherwise
The World Health Organization releases guidelines and supports initiatives for the surveillance, prevention, and control of diabetes and its complications